Taking Mounjaro and having a steroid injection: the clinical picture

You've been offered a steroid injection for your shoulder — and you're mid-way through your Mounjaro course

This is exactly the situation many people find themselves in. Corticosteroid injections, whether into a joint, a tendon, or an inflamed tissue, are a routine part of managing musculoskeletal pain. They are also potent agents that travel beyond the injection site. Even a local intra-articular steroid such as triamcinolone or methylprednisolone enters the bloodstream to some degree, and once it does, it signals the liver to release more glucose and reduces the ability of muscle and fat cells to absorb it. The result is a transient but sometimes significant rise in blood sugar.

Tirzepatide works partly by boosting insulin release in response to meals and by slowing gastric emptying, both of which help keep glucose levels steady. A corticosteroid injection does the opposite. For people using Mounjaro purely for weight management who do not have diabetes, this temporary rise is unlikely to cause an acute crisis, but it is still a change worth flagging. For those who also have type 2 diabetes, the glucose spike can be more pronounced and last several days, particularly after a depot preparation such as Depo-Medrone. The NHS patient information for tirzepatide notes that other medicines affecting blood sugar should be discussed with your prescriber, and corticosteroids fit squarely in that category.

Tell the clinician giving the steroid injection that you are on tirzepatide. Tell your Mounjaro prescriber it is planned or has happened. That two-way communication is the practical step that matters most here.

Why the type of steroid injection changes the calculation

Not all steroid injections carry the same metabolic weight. A short-acting local anaesthetic-steroid combination used in, say, a trigger-point injection may produce a blood-glucose effect that resolves within a day or two. A longer-acting depot preparation, the kind often used in the hip, knee or shoulder, can affect glucose for a week or more. Systemic steroids taken by mouth or given intravenously carry the broadest and most sustained effect, though those are a different category from the joint injections most people are thinking about when they search this topic.

Separately, if you are curious about Mounjaro and Depo injections in the contraceptive sense, that is a distinct topic: Depo-Provera is a progestogen contraceptive, not a corticosteroid, and the considerations differ. The word "depot" creates genuine confusion here, and it is worth knowing which type of depot injection your clinician is discussing.

There is also a practical question about oral contraceptive absorption if you are a woman of reproductive age on the pill alongside Mounjaro. Because tirzepatide slows how quickly food and medicines leave your stomach, the MHRA advises adding a non-oral contraceptive method for the first four weeks of treatment and for four weeks after each dose increase, in case pill absorption is affected. This is separate from the steroid question but often comes up alongside it.

What the interaction means in practice, and when to seek advice

Most people who receive a single local steroid injection while on Mounjaro will not experience a dramatic change. The effect on glucose is real but self-limiting. What you should watch for in the days following is increased thirst, frequent urination, or feeling more fatigued than usual, signs that blood glucose may be running higher than normal. If you have a glucose monitor, use it. If you do not, and you develop any of those symptoms noticeably, contact your prescriber or GP promptly.

For context on what Mounjaro's clinical picture looks like more broadly, the Mounjaro treatment overview sets out the licence, the titration schedule and what the evidence says about how it works. Our guide to Mounjaro injection sites may also be useful if you are thinking about how to manage your weekly tirzepatide injection alongside any local tenderness from a steroid procedure nearby.

If the steroid injection is going into tissue close to your usual Mounjaro injection site (your abdomen, thigh or upper arm) rotate to a different site for your next weekly dose. Inflamed or recently injected tissue is not ideal for subcutaneous absorption, and if you notice your Mounjaro injection site is red and itchy after a procedure nearby, it is worth monitoring closely and mentioning to your prescriber. Our prescribers are available seven days a week if you have questions about managing your schedule; reach out via the contact page or through your aftercare channel.

Bringing this conversation to your prescriber before anything is administered

The most sensible step is also the most obvious one: raise it before the steroid injection happens, not after. When you see the specialist or GP administering the corticosteroid, mention you are on tirzepatide. When you have your next Mounjaro clinical review, mention the steroid injection is planned. If you are due a dose increase around the same time, your prescriber may have a view on the timing.

At nume, a real clinician reads your consultation, not a decision tree. If anything about your situation has changed since you started, including a planned procedure, our prescribers want to know. That is also why we carry out a clinical review before every repeat order, not just at sign-up. You can read more about our clinical team and how prescribing decisions are made.

The cost of treatment, and what that includes, is covered on our treatment page. One transparent price covers the consultation, prescription, clinical review and next-working-day DPD delivery in plain packaging, and the Mounjaro injection pens arrive tracked and discreet, with no indication of what is inside. If you have questions about whether Mounjaro is appropriate for your situation right now, starting a free consultation is the straightforward next step. The MHRA's Yellow Card scheme is also open to patients who want to report any unexpected effects from their treatment.